SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Set the Controls For The Heart of the SUN
IQ 1.840-1.6%Dec 19 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Doug R1/6/2020 9:20:41 PM
1 Recommendation

Recommended By
RWS

   of 1156
 
Fits the TA profile of "high beta interesting" alright....

What does smart money think about Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)?
finance.yahoo.com
At Q3's end, a total of 10 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 25% from the second quarter of 2019. The graph below displays the number of hedge funds with bullish position in GLMD over the last 17 quarters. So, let's see which hedge funds were among the top holders of the stock and which hedge funds were making big moves.



View photo
Among these funds, Biotechnology Value Fund held the most valuable stake in Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), which was worth $8.8 million at the end of the third quarter. On the second spot was 683 Capital Partners which amassed $6.5 million worth of shares. Vivo Capital, Nantahala Capital Management, and Baker Bros. Advisors were also very fond of the stock, becoming one of the largest hedge fund holders of the company. In terms of the portfolio weights assigned to each position Biotechnology Value Fund allocated the biggest weight to Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), around 0.92% of its 13F portfolio. 683 Capital Partners is also relatively very bullish on the stock, designating 0.72 percent of its 13F equity portfolio to GLMD.

Consequently, key money managers have jumped into Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) headfirst. Marshall Wace, managed by Paul Marshall and Ian Wace, initiated the largest position in Galmed Pharmaceuticals Ltd (NASDAQ:GLMD). Marshall Wace had $0.1 million invested in the company at the end of the quarter. John Zaro's Bourgeon Capital also made a $0 million investment in the stock during the quarter.

Let's check out hedge fund activity in other stocks - not necessarily in the same industry as Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) but similarly valued. These stocks are I.D. Systems, Inc. (NASDAQ: IDSY --** now PWFL), Citizens Holding Company (NASDAQ: CIZN), Grindrod Shipping Holdings Ltd. (NASDAQ: GRIN), and TravelCenters of America LLC (NYSE: TA). All of these stocks' market caps resemble GLMD's market cap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext